Short Interest in CV Sciences, Inc. (OTCMKTS:CVSI) Decreases By 13.1%

CV Sciences, Inc. (OTCMKTS:CVSI) was the recipient of a significant decline in short interest during the month of January. As of January 30th, there was short interest totaling 12,867 shares, a decline of 13.1% from the January 15th total of 14,803 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 823,759 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily trading volume, of 823,759 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the shares of the stock are sold short.

CV Sciences Stock Performance

OTCMKTS CVSI opened at $0.05 on Tuesday. CV Sciences has a twelve month low of $0.02 and a twelve month high of $0.10. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.07 and a quick ratio of 0.21. The business’s fifty day moving average is $0.05 and its 200 day moving average is $0.04.

CV Sciences Company Profile

CV Sciences, Inc is a developer, manufacturer and marketer of hemp-derived products, with a focus on cannabidiol (CBD) formulations for both consumer and industrial applications. The company’s consumer segment offers a range of dietary supplements, topical creams, personal care items and pet products under its flagship PlusCBD™ Oil brand, while its industrial segment provides hemp-derived ingredients for use in wellness, pharmaceutical and cosmetic formulations.

Headquartered in San Diego, California, CV Sciences operates a manufacturing facility in El Cajon that oversees cultivation partnerships, extraction, refinement and product formulation.